TMCnet News Invests in Vesttoo
[January 07, 2021] Invests in Vesttoo

TEL AVIV, Israel, Jan. 7, 2021 /PRNewswire/ -- Vesttoo is proud to announce that, which invests in the most connected and prominent leaders in the longevity economy field, has joined Vesttoo as a shareholder through an equity investment. The investment demonstrates the importance of Vesttoo's technology, which harnesses the power of AI and machine learning to forecast and price long-tail risks such as longevity, excess mortality, lapse, as well as Value-in-Force (VIF) monetization and excess mortality Industry Loss Warranties (ILW) and transfer them to the capital markets.


Vesttoo Logo


"We are very happy to have on board. Their investment is a huge vote of confidence for Vesttoo's revolutionary risk modeling technology. Taking advantage of AI-based technologies to assess, price and transfer risk to the capital markets is the best way to bridge the insurance industry's funding gap and face the industry's challenges, especially post Covid-19 stress," said Yaniv Bertele, CEO of Vesttoo.

"We are excited to support Vesttoo's revolutionry approach to the conservative insurance industry. The aging population and the new scientific discoveries creates an unprecedented challenge for understanding and predicting future risks," said Petr Sramek, Managing Partner of

Vesttoo specializes in data-driven risk management solutions for the P&C and L&P markets, using cutting-edge technologies to transfer general insurance, lapse, mortality and longevity risk to the capital markets, as well as VIF securitization and excess mortality ILW. The company provides insurers and pension funds with affordable, flexible and strategic risk transfer to the capital markets, while investors benefit from uncorrelated, high-yield investments with remote loss possibilities.                        

Using its cutting-edge proprietary AI and machine learning stochastic algorithms, Vesttoo creates highly accurate risk models and forecasts. Vesttoo transforms the way securities are structured, offered, and traded, providing an accessible, flexible, scalable, and affordable streamlined alternative to traditional reinsurance. invests in the best of worldwide longevity-related companies based on close cooperation with top scientists in the field of longevity-related insurtech and fintech, aging research and rejuvenation, biotechnology, bioinformatics, agetech, and related AI. The fund provides an active approach with entrepreneurial help, network and commercialization support.

The fund boasts decades of experience in building and mentoring high-tech start-ups, while its founders previously managed and exited multiple start-ups, including a start-up accelerator.

Media contact:
Lior Fuerst, Business Development

Cision View original content:

SOURCE Vesttoo

[ Back To's Homepage ]